Vesiculate is an Australian nanotechnology company that produces precisely engineered, monodisperse synthetic vesicle reference standards (Syncles) to standardize and improve the accuracy of nanoparticle analysis in research and development.
Vesiculate is a nanotechnology company that develops and manufactures monodisperse synthetic vesicle reference materials, branded as Syncles. These nanoparticles are engineered to serve as standardized benchmarks for the analysis of various biological and synthetic nanoparticle platforms, including extracellular vesicles, lipid nanoparticles, virus-like particles, and liposomes. The company utilizes proprietary manufacturing technology to produce these stable, non-lipid vesicles, which are designed to offer superior consistency, structural uniformity, and environmental durability compared to traditional lipid-based standards. By providing precise, reproducible reference materials, Vesiculate aims to eliminate analytical ambiguity and enable accurate instrument calibration for researchers and laboratories.
These reference materials are critical for ensuring data integrity across scientific and clinical research workflows, helping researchers validate instrument performance and compare data across different laboratories. By addressing the challenges of measuring nanoscale objects, which are highly sensitive to measurement variables, Vesiculate supports the development of more reliable scientific insights and clinical translations. The company, which is based in Sydney, Australia, operates out of Macquarie University and the UNSW Sydney ecosystem, maintaining complete vertical integration in their design, synthesis, and validation processes to uphold rigorous quality standards.